2010 Advertising Contracts Marketing 
IP and Legal Filings
NOVEMBER 6, 2022
As a result, the sector works closely with various performers, artists, authors, publishers, production companies, record labels, online content providers, broadcasters, advertising, distributors, etc. Or whether the agencies should be provided royalties for the same if the idea is used for marketing purposes after their contract has ended?
Technology & Marketing Law Blog
JUNE 10, 2022
Breach of contract, perhaps? But that would only be enforceable by users in contract privity). Is it false advertising for Facebook to describe the groups as “private”? Does that create a claim for false advertising? HDR appeared first on Technology & Marketing Law Blog. June 8, 2022).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Technology & Marketing Law Blog
OCTOBER 19, 2021
Nevertheless, because adware often provided poor consumer experiences, adware largely fizzled out by 2010. Implied-in-Law Contract/Unjust Enrichment. WhenU concluded that copyright was a dead-end. 1-800 Contacts v. WhenU concluded that trademarks was a dead-end. As a result, the legal issues rarely are litigated any more. * * *.
Technology & Marketing Law Blog
SEPTEMBER 28, 2021
Read literally, all advertising “allow[s] for arranging the sale or purchase of goods,” so this law potentially obligates EVERY ad-supported publisher to undertake the content moderation obligations the bill imposes on online marketplaces. Normally trademark owners aren’t third-party beneficiaries of that contract.
SpicyIP
NOVEMBER 8, 2023
Speaking of this topic, I can’t miss Bedaquiline , the first new drug to receive approval to treat tuberculosis (TB) in over 40 years, which raised serious questions about its marketing approval without mandatory Phase III clinical trials in India and around informed consent of Indian patients. Well, this wraps up our Octobers’ sift.
Fish & Richardson Trademark & Copyright Thoughts
MARCH 8, 2021
The abbreviated biosimilar licensure pathway created by the Biologics Price Competition and Innovation Act (BPCIA) in 2010 was designed to increase competition for biologics and reduce healthcare costs. Already, FDA has licensed almost 30 biosimilars, nearly 20 of which are available to patients in the United States.
Kluwer Copyright Blog
NOVEMBER 24, 2021
Copyright contract law (Sections 31 et seqq. In another decision , from 2016, the BGH found that remuneration claims under Section 32 UrhG arise when the agreed remuneration at the time of the respective contract being concluded is not appropriate when viewed from the perspective of the time of conclusion of the contract (ex-ante view).
Expert insights. Personalized for you.
52 
Let's personalize your content